HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mei-Chuan Chen Selected Research
Mei-Chuan Chen Research Topics
Disease
19
Neoplasms (Cancer)
12/2021 - 01/2012
5
Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 05/2014
5
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2020 - 01/2012
4
Infections
01/2022 - 05/2013
3
Prostatic Neoplasms (Prostate Cancer)
12/2021 - 03/2011
3
Hepatocellular Carcinoma (Hepatoma)
01/2016 - 01/2011
2
Lung Neoplasms (Lung Cancer)
12/2021 - 08/2013
2
Ovarian Neoplasms (Ovarian Cancer)
01/2017 - 01/2016
1
Lung Injury
01/2022
1
Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022
1
Critical Illness (Critically Ill)
01/2022
1
COVID-19
01/2022
1
Fibrosis (Cirrhosis)
06/2021
1
Asthma (Bronchial Asthma)
01/2021
1
Airway Remodeling
01/2021
1
Disease Progression
10/2020
1
Urinary Bladder Neoplasms (Bladder Cancer)
01/2020
1
Nephritis
01/2018
1
Pneumonia (Pneumonitis)
01/2018
1
Hypercholesterolemia
01/2017
1
Hyperlipidemias (Hyperlipidemia)
01/2017
1
Colonic Neoplasms (Colon Cancer)
01/2017
1
Polyploidy
01/2016
1
Pancreatic Neoplasms (Pancreatic Cancer)
01/2016
1
Carcinoma (Carcinomatosis)
01/2016
1
Rhabdomyolysis
03/2015
1
Acute Intermittent Porphyria (Porphyria, Acute)
03/2015
1
Humeral Fractures
07/2014
1
Liver Neoplasms (Liver Cancer)
03/2014
Drug/Important Bio-Agent (IBA)
4
Histone Deacetylase Inhibitors
IBA
06/2021 - 01/2011
3
Antineoplastic Agents (Antineoplastics)
IBA
10/2020 - 01/2016
3
Histone Deacetylases (Histone Deacetylase)
IBA
10/2019 - 01/2011
3
Tubulin
IBA
01/2019 - 09/2014
2
Hydroxamic Acids (Hydroxamic Acid)
IBA
12/2021 - 02/2017
2
quinoline
IBA
12/2021 - 10/2019
2
B7-H1 Antigen
IBA
03/2020 - 10/2019
2
Flavonoids
IBA
05/2019 - 04/2017
2
artocarpin lectin
IBA
05/2019 - 04/2017
2
Phosphotransferases (Kinase)
IBA
01/2017 - 01/2014
2
Benzenesulfonamides
IBA
01/2017 - 08/2015
2
Pharmaceutical Preparations
IBA
01/2016 - 06/2015
2
Histone Deacetylase 6
IBA
10/2015 - 05/2014
2
Type II DNA Topoisomerases (Topoisomerase II)
IBA
01/2014 - 01/2012
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
01/2022
1
C-Reactive Protein
IBA
01/2022
1
Ferritins (Ferritin)
IBA
01/2022
1
Pargyline (Pargyline Hydrochloride)
FDA Link
12/2021
1
Protein Isoforms (Isoforms)
IBA
12/2021
1
Acids
IBA
12/2021
1
Collagen
IBA
06/2021
1
Plasminogen Activator Inhibitor 1
IBA
06/2021
1
Plasminogen Activators (Plasminogen Activator)
IBA
06/2021
1
lipoteichoic acid
IBA
06/2021
1
Doxycycline (Periostat)
FDA Link
Generic
06/2021
1
Biological Products
IBA
01/2021
1
Interleukin-33
IBA
01/2021
1
Omalizumab (Xolair)
FDA Link
01/2021
1
Interleukin-13
IBA
01/2021
1
Angiogenesis Inhibitors
IBA
01/2021
1
anti-IgE antibodies
IBA
01/2021
1
Afatinib
IBA
03/2020
1
compound 17
IBA
03/2020
1
Immune Checkpoint Inhibitors
IBA
01/2020
1
erdafitinib
IBA
01/2020
1
Catenins
IBA
01/2020
1
Proteins (Proteins, Gene)
FDA Link
01/2020
1
pyrimidine
IBA
01/2020
1
PF-670462
IBA
01/2020
1
Amides
IBA
10/2019
1
resorcinol (resorcin)
IBA
10/2019
1
benzamide
IBA
01/2019
1
SS-A antibodies
IBA
01/2018
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2018
1
Zinc
IBA
02/2017
1
dactolisib
IBA
01/2017
1
Cyclin B1
IBA
01/2017
1
dendrophenol
IBA
01/2017
1
antroquinonol
IBA
01/2017
1
4-acetylantroquinonol B
IBA
01/2017
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2016
1
Ligands
IBA
01/2016
1
3- (1- (4- methoxybenzenesulfonyl)- 2,3- dihydro- 1H- indol- 5- yl)- N- hydroxyacrylamide
IBA
01/2016
1
Caspases
IBA
01/2016
1
Cisplatin (Platino)
FDA Link
Generic
01/2016
1
Antimitotic Agents
IBA
01/2016
1
compound 21
IBA
08/2015
1
diphenyl (biphenyl)
IBA
08/2015
1
Ribonucleotide Reductases (Ribonucleotide Reductase)
IBA
06/2015
1
Antimetabolites
IBA
06/2015
1
Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)
IBA
03/2015
1
7- (4- cyanophenylamino)- 1- (4- methoxybenzenesulfonyl)indoline
IBA
09/2014
1
7-azaindole dimer
IBA
05/2014
1
Sorafenib (BAY 43-9006)
FDA Link
03/2014
1
3- (1- benzenesulfonyl- 2,3- dihydro- 1H- indol- 5- yl)- N- hydroxyacrylamide
IBA
03/2014
Therapy/Procedure
9
Therapeutics
01/2022 - 03/2011
2
Fracture Fixation
01/2015 - 07/2014
1
Intravenous Infusions
01/2022
1
Bone Lengthening
01/2015
1
Bone Wires
07/2014
1
Postoperative Care
07/2014